The president and executive vice president of the American Chamber of Commerce of the Dominican Republic (AMCHAMDR) received a courtesy visit from Pfizer's regional director for Central America and the Caribbean, Roberto Dormond, to discuss the strategic plans of both institutions.

Ramón Ortega and William Malamud highlighted the leadership AMCHAMDR has maintained for more than nine decades in strengthening the investment climate and promoting trade between the Dominican Republic and the United States.

“At AMCHAMDR, we organize more than 50 activities throughout the year, including our monthly luncheons, themed events for five Working Committees, trade missions, golf tournaments, and others. All of these activities are linked to topics aligned with our institution's mission to promote trade and the investment climate in the country with our main trading partner,” Malamud stated.

Ortega and Malamud explained that this year the American Chamber of Commerce has set a cross-cutting objective to promote a culture of innovation and digital transformation in the country's companies, and that it will rely on the work of its various Working Committees to achieve this goal.

“During my tenure as president, I have focused on integrating innovation and technology into the American Chamber of Commerce to provide our more than 1,600 members with a more comprehensive and efficient experience. That's why we are focusing on fostering digital transformation in companies, because we understand that this is in line with global trends,” said Ortega.

Pfizer's regional director for Central America and the Caribbean expressed interest in the digital transformation process being carried out by AMCHAMDR and highlighted the advances in technological innovation for drug development being implemented by the leading biomedical research company.

During the meeting, Dormond announced that the company is working on the development of new molecules for treatments in cancer, rare diseases, inflammation, and immunology.

On the other hand, a senior Pfizer executive recognized the added value that the American Chambers of Commerce bring to their membership in the countries where they operate.

Commenting on his company's experience as a partner in various American Chambers of Commerce (AMCHAMs), Dormond emphasized the importance of the American Chambers of Commerce, especially for their role in promoting the rule of law, institutional transparency, and establishing public-private partnerships that benefit the business and investment climate in different countries.

The meeting between AMCHAMDR executives and Pfizer was held at the consulting firm PriceWaterhouseCoopers, located in the Novocentro Business Tower.

The American Chamber of Commerce of the Dominican Republic is a nonprofit association legally incorporated on November 8, 1923, affiliated with the U.S. Chamber of Commerce and a founding member of the Association of American Chambers of Commerce in Latin America (AACCLA).

Furthermore, it fosters a healthy investment climate based on access to knowledge, opportunities, and a culture of best practices for the socioeconomic and professional development of its members.